Integration of gamma knife surgery in the management of cerebral metastases from melanoma

Melanoma Research

Volumn 16, Issue 1, 2006, Pages 51-57

  Christopoulou, Athena ^a   Retsas, Spyros ^a   Kingsley, Derek ^a   Paddick, Ian ^a   Lindquist, Christer ^a  

^a CROMWELL HOSPITAL   (United Kingdom)

Author keywords

Cerebral; Chemotherapy; Gamma knife; Melanoma; Metastases; Radiosurgery; Response; Survival

Indexed keywords

DACARBAZINE; FOTEMUSTINE; PACLITAXEL; PLATINUM DERIVATIVE; TEMOZOLOMIDE; VINCA ALKALOID;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER DIAGNOSIS; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GAMMA KNIFE RADIOSURGERY; HUMAN; MALE; MELANOMA; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TUMOR REGRESSION; TUMOR VOLUME; BRAIN TUMOR; COMPARATIVE STUDY; METASTASIS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RADIOSURGERY; RETROSPECTIVE STUDY; SKIN TUMOR; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; BRAIN NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOSURGERY; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33645461535     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cmr.0000198451.26827.b2     Document Type: Article

References (24)

1. Lindquist C. Gamma knife surgery for recurrent solitary metastasis of a cerebral hypernephroma: case report. Neurosurgery 1989; 25:802-804.
2. Kihlstrom L, Karlsson B, Lindquist C. Gamma knife surgery for cerebral metastases. Implications for survival based on 16 years experience. Stereotact Funct Neurosurg 1993; 61 (Suppl 1):45-50.
3. Radbill AE, Fiveash JF, Falkenberg ET, Guthrie BL, Young PE, Meleth S, et al. Initial treatment of melanoma brain metastases using gamma knife radiosurgery: an evaluation of efficacy and toxicity. Cancer 2004; 101:825-833.
4. Yu C, Chen JC, Apuzzo ML, O'Day S, Giannotta SL, Weber JS, et al. Metastatic melanoma to the brain: prognostic factors after gamma knife radiosurgery. Int J Radiat Oncol Biol Phys 2002; 52:1277-1287.
5. Schoeggl A, Kitz K, Ertl A, Reddy M, Bavinzski G, Schneider B. Prognostic factor analysis for multiple brain metastases after gamma knife radiosurgery: results in 97 patients. J Neurooncol 1999; 42:169-175.
6. Gonzalez-Martinez J, Hernandez L, Zamorano L, Sloan A, Levin K, Lo S, et al. Gamma knife radiosurgery for intracranial metastatic melanoma: a 6-year experience. J Neurosurg 2002; 97 (5 Suppl):494-498.
7. Seung SK, Sneed PK, McDermott MW, Shu HK, Leong SP, Chang S, et al. Gamma knife radiosurgery for malignant melanoma brain metastases. Cancer J Sci Am 1998; 4:103-109.
8. Marcou Y, Lindquist C, Adams C, Retsas S, Plowman PN. What is the optimal therapy of brain metastases? Clin Oncol (R Coll Radiol) 2001; 13:105-111.
9. Retsas S, Gershuny AR. Central nervous system involvement in malignant melanoma. Cancer 1988; 61:1926-1934.
10. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997; 37:745-751.
11. Retsas S, Henry K, Mohammed MQ, Macrae K. Prognostic factors of cutaneous melanoma and a new staging system proposed by the American Joint Committee on Cancer (AJCC): validation in a cohort of 1284 patients. Eur J Cancer 2002; 38:511-516.
12. Mohammed MQ, Abraha HD, Sherwood RA, Macrae K, Retsas S. Serum S100beta protein as a marker of disease activity in patients with malignant melanoma. Med Oncol 2001; 18:109-120.
13. Gerosa M, Nicolato A, Foroni R. The role of gamma knife radiosurgery in the treatment of primary and metastatic brain tumors. Curr Opin Oncol 2003; 15:188-196.
14. Nieder C, Andratschke N, Grosu AL, Molls M. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases. Strahlenther Onkol 2003; 179:16-20.
15. DiBiase SJ, Chin LS, Ma L. Influence of gamma knife radiosurgery on the quality of life in patients with brain metastases. Am J Clin Oncol 2002; 25:131-134.
16. Lavine SD, Petrovich Z, Cohen-Gadol AA, Masri LS, Morton DL, O'Day SJ, et al. Gamma knife radiosurgery for metastatic melanoma: an analysis of survival, outcome, and complications. Neurosurgery 1999; 44:59-64.
17. Stone A, Cooper J, Koenig KL, Golfinos JG, Oratz R. A comparison of survival rates for treatment of melanoma metastatic to the brain. Cancer Invest 2004; 22:492-497.
18. Dvorak J, Melichar B, Zizka J, Hadzi-Nikolov D, Petera J. Complete response of multiple melanoma brain metastases after treatment with temozolomide. Onkologie 2004; 27:171-174.
19. Retsas S, Bayliss MA, Sheikh MN, Chong SL, Bafaloukos D. Chemotherapy of malignant melanoma; the European experience. La Revue de Medicine Interne 1990; XI (2 Suppl):51-58.
20. Falkson CI, Falkson G, Falkson HC. Phase II trial of fotemustine in patients with metastatic malignant melanoma. Invest New Drugs 1994; 12:251-254.
21. Khayat D, Giroux B, Berille J, Cour V, Gerard B, Sarkany M, et al. Fotemustine in the treatment of brain primary tumors and metastases. Cancer Invest 1994; 12:414-420.
22. Hwu WJ, Raizer J, Panageas KS, Lis E. Treatment of metastatic melanoma in the brain with temozolomide and thalidomide. Lancet Oncol 2001; 2:634-635.
23. Bafaloukos D, Gogas H, Georgoulias V, Briassoulis E, Fountzilas G, Samantas E, et al. Temozolomide in combination with docetaxel in patients with advanced melanoma: a phase II study of the Hellenic Cooperative Oncology Group. J Clin Oncol 2002; 20:420-425.
24. Retsas S, Mohith A, Mackenzie H. Taxol and vinorelbine: a new active combination for disseminated malignant melanoma. Anticancer Drugs 1996; 7:161-165.